A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.

Abstract

BACKGROUND A previous pilot study of open-label mirtazapine augmentation conducted by the authors in 20 depressed patients yielded a 55% response rate at week 4. A double-blind controlled trial was undertaken to further elucidate the efficacy of this intervention. METHODS 26 adult outpatients with persistent major depression despite adequate… (More)

Topics

Cite this paper

@article{Carpenter2002ADP, title={A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.}, author={Linda L. Carpenter and Sarah Yasmin and Lawrence H. Price}, journal={Biological psychiatry}, year={2002}, volume={51 2}, pages={183-8} }